Medically reviewed by Kelly Wood, MD Zepbound (tirzepatide) is a once-a-week injectable weight-loss medication. It helps ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

It will connect people to a healthcare professional who will review their history ... pharmacy a person uses. Zepbound is an FDA-approved medication for weight loss, meaning that commercial ...

The implications—if Lilly’s drug makes it through the testing and review process—could ... About 100,000 people purchase Zepbound for weight loss through Lilly Direct each month, which ...

Pfizer to discontinue danuglipron weight-loss drug, but has other obesity treatments ... participant stopped taking danuglipron. "After a review of the totality of information, including all ...